{"schema_version":"1","generated_at":"2026-11-08T06:46:05.590Z","data_as_of":"2026-11-08","url":"https://www.findmykol.com/kol/vinay-prasad","json_url":"https://www.findmykol.com/kol/vinay-prasad/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"vinay-prasad","name":"Vinay Prasad","credential":"MD","title":"Professor of Epidemiology and Biostatistics and Medicine, School of Medicine, UCSF","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"University of California, San Francisco","institution_url":"https://www.findmykol.com/institution/university-of-california-san-francisco","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1467786277","orcid":"0000-0002-6110-8221","openalex":"A5007770903"},"summary":"Vinay Prasad is Professor of Epidemiology and Biostatistics and Medicine, School of Medicine, UCSF at University of California, San Francisco. OpenAlex indexes 608 publications with 16,870 citations (h-index 58).","overview":{"text":"Vinay Prasad, MD, is Professor of Epidemiology and Biostatistics and Medicine, School of Medicine, UCSF at University of California, San Francisco. The public record shows 608 publications with 16,870 citations (h-index 58), centered on Statistical Methods in Clinical Trials, Pharmaceutical industry and healthcare, Pharmaceutical Economics and Policy. It also documents industry payments reported by 2 companies.","bullets":["Most recent indexed publication: 2025 · Molecular cancer therapeutics","Top research focus: Statistical Methods in Clinical Trials","Open Payments reporting from 2 companies"],"generated_at":"2026-11-08"},"focus":{"indications":[{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"ESRD / Dialysis","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Atrial Fibrillation","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Stroke","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Depression (MDD)","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1},{"label":"Bipolar Disorder","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Heart Failure","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Coronary Artery Disease / ACS","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Hypertension","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"ALS","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Alzheimer's / Dementia","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"IBS / Functional GI","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Asthma","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"COPD","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"IBD (Crohn's / UC)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Acne / Hidradenitis","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1},{"label":"Cushing's Syndrome","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Type 2 Diabetes","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Substance Use Disorders","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1}],"research_topics":["Statistical Methods in Clinical Trials","Pharmaceutical industry and healthcare","Pharmaceutical Economics and Policy","Meta-analysis and systematic reviews","Health Systems, Economic Evaluations, Quality of Life"],"works_with":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"ConvaTec Inc.","trials":0,"payments":1,"mentions":1},{"name":"Sonendo Inc","trials":0,"payments":1,"mentions":1}]}},"scholarship":{"works_count":608,"cited_by_count":16870,"h_index":58,"i10_index":262,"pubmed_count":44,"latest_activity_year":2025,"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":2025},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"ConvaTec Inc.","program_year":2025,"amount_usd":17.58,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467786277"},{"payer":"Sonendo Inc","program_year":2021,"amount_usd":5435.95,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467786277"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1467786277","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":17,"years":{"first":2017,"last":2025},"societies":["AGA","ASCO","ASH","ASTRO","ENDO"],"shown":3,"withheld":14,"rows":[{"title":"MON-362 Endocrine Immune-Related Adverse Events in Immune Checkpoint Inhibitor Therapy: Insights Across Cancer Types and Treatment Stages","society":"ENDO","meeting":"ENDO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1210/jendso/bvaf149.2138","source_url":"https://doi.org/10.1210/jendso/bvaf149.2138","status":"verified"},{"title":"Bridging therapies used in trials testing CAR-T therapies.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2024,"role":"presenting_author","presentation_type":"unknown","contribution_type":"online_abstract","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e19011","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e19011","status":"verified"},{"title":"ASCO oral presenters five years later: Leaks in the pipeline?","society":"ASCO","meeting":"ASCO Annual Meeting","year":2022,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.11019","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.11019","status":"verified"}],"source":"congress"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.","year":2025,"journal":"Molecular cancer therapeutics","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40638518/","status":"verified"},{"title":"Characterization of bridging therapies in clinical trials leading to FDA approval of CAR-T cell therapies.","year":2025,"journal":"International journal of cancer","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40394455/","status":"verified"},{"title":"Reply to 'Surrogate end points in oncology: aligning drug development incentives and patient needs'.","year":2025,"journal":"Nature reviews. Clinical oncology","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40481326/","status":"verified"},{"title":"The cost of emulated target trials: Is real-world data cheaper than randomized studies?","year":2025,"journal":"European journal of clinical investigation","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40130313/","status":"verified"},{"title":"How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysis.","year":2025,"journal":"International journal of cancer","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39887747/","status":"verified"}],"most_cited":{"total":608,"shown":5,"withheld":603,"rows":[{"title":"Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs","year":2019,"cited_by_count":1422,"type":"article","source_url":"https://doi.org/10.1001/jamanetworkopen.2019.2535"},{"title":"Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices","year":2014,"cited_by_count":737,"type":"editorial","source_url":"https://doi.org/10.1186/1748-5908-9-1"},{"title":"Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval","year":2017,"cited_by_count":531,"type":"article","source_url":"https://doi.org/10.1001/jamainternmed.2017.3601"},{"title":"The high price of anticancer drugs: origins, implications, barriers, solutions","year":2017,"cited_by_count":441,"type":"review","source_url":"https://doi.org/10.1038/nrclinonc.2017.31"},{"title":"The Strength of Association Between Surrogate End Points and Survival in Oncology","year":2015,"cited_by_count":417,"type":"article","source_url":"https://doi.org/10.1001/jamainternmed.2015.2829"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Alyson Haslam","coauthored_works":138},{"name":"Timothée Olivier","coauthored_works":63,"profile_url":"https://www.findmykol.com/kol/timothee-olivier"},{"name":"Adam S. Cifu","coauthored_works":27}],"source":"works"},"presence":{"mentions":{"total":1,"shown":1,"rows":[{"url":"https://amp.profiles.ucsf.edu/vinayak.prasad","label":"Writes a Substack and co-writes Sensible Medicine","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, University of Chicago","source_url":"https://amp.profiles.ucsf.edu/vinayak.prasad","status":"verified","collected_at":"2026-11-08"},{"value":"MPH, Johns Hopkins University","source_url":"https://amp.profiles.ucsf.edu/vinayak.prasad","status":"verified","collected_at":"2026-11-08"}]},"awards":{"total":6,"shown":3,"rows":[{"value":"Distinguished Contribution to Teaching Award at UCSF (2023)","source_url":"https://amp.profiles.ucsf.edu/vinayak.prasad","status":"verified","collected_at":"2026-11-08"},{"value":"Excellence in Teaching Award at UCSF (2022)","source_url":"https://amp.profiles.ucsf.edu/vinayak.prasad","status":"verified","collected_at":"2026-11-08"},{"value":"Craig Okada award for best teacher in the hematology oncology fellowship program","source_url":"https://amp.profiles.ucsf.edu/vinayak.prasad","status":"verified","collected_at":"2026-11-08"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Hosts the oncology podcast Plenary Session","source_url":"https://vinayakkprasad.com/","status":"provisional","collected_at":"2026-11-08"}]}},"similar":[{"name":"Talmadge King","slug":"talmadge-king","institution":"University of California, San Francisco","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/talmadge-king","json_url":"https://www.findmykol.com/kol/talmadge-king/profile.json"},{"name":"Adil Daud","slug":"adil-daud","institution":"University of California, San Francisco","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/adil-daud","json_url":"https://www.findmykol.com/kol/adil-daud/profile.json"},{"name":"Emmanuelle Waubant","slug":"emmanuelle-waubant","institution":"University of California, San Francisco","specialty":"Neurology","url":"https://www.findmykol.com/kol/emmanuelle-waubant","json_url":"https://www.findmykol.com/kol/emmanuelle-waubant/profile.json"},{"name":"Peter Ganz","slug":"peter-ganz","institution":"University of California, San Francisco","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/peter-ganz","json_url":"https://www.findmykol.com/kol/peter-ganz/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":14,"publications":39,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-08"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-08"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-08"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-08"}},"methodology_url":"https://www.findmykol.com/about#methodology"}